• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT MEDICAL AMPLATZER SEPTAL OCCLUDER; TRANSCATHETER SEPTAL OCCLUDER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT MEDICAL AMPLATZER SEPTAL OCCLUDER; TRANSCATHETER SEPTAL OCCLUDER Back to Search Results
Catalog Number 9-ASD-015
Medical Device Problem Code Premature Separation (4045)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 08/21/2024
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
An event of premature separation during procedure and device embolization was reported.A returned device assessment could not be performed as the device was not returned for analysis.It is possible due to procedural conditions when performing the push and pull maneuver of the device which may have caused the reported incident.However, this cannot be confirmed.The device history record was reviewed to ensure that each manufacturing and inspection operation was performed and the product met all specifications.Based on the information received, the cause of the reported premature separation could not be conclusively determined.There is no indication of a product quality issue with respect to labeling design or manufacturing of the device.
 
Event or Problem Description
It was reported that on 21 aug.2024, a 15mm amplatzer septal occluder was selected for implant.During the procedure, when deploying the device, the left disc didn't expand as usual.Device was partially recapture was performed twice, but was difficult.Therefore the user expanded both discs (left and right disc) in the right atrium (ra), and an attempt was made to push out the left disc.The device was then found to have dislodged from the delivery cable and dropped into the ra.A percutaneous snare was used to retrieve the device.The patient remained hemodynamically stable throughout the procedure and there was no clinically significant delay.There was no health impact recorded.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
AMPLATZER SEPTAL OCCLUDER
Common Device Name
TRANSCATHETER SEPTAL OCCLUDER
Manufacturer (Section D)
ABBOTT MEDICAL
5050 nathan lane n
plymouth MN 55442
Manufacturer (Section G)
ST. JUDE MEDICAL #3014918977
edificio #44 calle 0, ave. 2
el coyol alajuela 1897- 4050
CS   1897-4050
Manufacturer Contact
karen krouse
5050 nathan lane n
plymouth, MN 55442
6517565400
MDR Report Key20212841
Report Number2135147-2024-04490
Device Sequence Number7202097
Product Code MLV
UDI-Device Identifier00811806010120
UDI-Public(01)00811806010120(17)260731(10)8082974
Combination Product (Y/N)N
Initial Reporter CountryJA
PMA/510(K) Number
P000039
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2024
Device Explanted Year2024
Serviced by Third Party (Y/N)N
Reporter Type Manufacturer
Report Source Foreign,Health Professional,Company Representative
Initial Reporter Occupation Physician
Type of Report Initial
Report Date (Section B) 09/13/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Operator of Device Health Professional
Device Expiration Date07/31/2026
Device Catalogue Number9-ASD-015
Device Lot Number8082974
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Initial
Initial Date Received by Manufacturer 08/21/2024
Initial Report FDA Received Date09/13/2024
Was Device Evaluated by Manufacturer? (Y/N) No
Date Device Manufactured08/05/2021
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Outcome Attributed to Adverse Event Required Intervention;
Patient Age7 YR
Patient SexFemale
-
-